As shown in Table 1, among cases with known EGFR status, EGFR mutation (EGFR+) was detected in 1,084 (57.29%) lung cancer cases, and EGFR wildtype (EGFR-) was detected in 808 cases (42.71%). The gene discussed is EGFR; the disease is lung carcinoma.